GrantRover ↗

← All opportunities

National Institutes of Health · United States

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials… (R01 Clinical Trial Required)

Full title in the source: National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)

Open

National Institutes of Health expects to make awards of up to $499,999 each, from a total budget of $499,999. Applications close on 7 Jan 2027. Eligible applicant types include public and State controlled institutions of higher education, state governments, nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education and 12 more.

Deadline
7 Jan 2027 (in 53 days)
Grant amount
Up to $499,999 per project
Funding rate
No mandatory cost sharing stated; funding percentage not stated
Total budget
$499,999
Cost sharing
Not required
Likely applicant types
Universities & research, Public bodies, Non-profits, SMEs / start-ups, Companies From source categories or programme rules; the call decides.
Funder
National Institutes of Health
Reference
PAR-25-081
Assistance listing
93.393 Cancer Cause and Prevention Research; 93.394 Cancer Detection and Diagnosis Research; 93.395 Cancer Treatment Research; 93.399 Cancer Control
Last checked
13 Nov 2026

Open the official call ↗ Add deadline to calendar

About this call

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initiated clinical trials focused on cancer-targeted diagnostic and therapeutic interventions of direct relevance to the research mission of DCTD and OHAM. The proposed project must involve at least 1 clinical trial related to the scientific interests of one or more of the following research programs: Cancer Therapy Evaluation Program, Cancer Imaging Program, Cancer Diagnosis Program, Radiation Research Program, Complementary and Alternative Medicine Program and/or the HIV and AIDS Malignancies Research Programs. Applicants may propose to conduct an early phase trial by itself, or in combination with another research aim(s) as appropriate.

Who can apply

Other Eligible Applicants include the following:

Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Applicant categories are a starting point. The official call decides eligibility.

Topics

Education Health

How to apply

  1. Read the full notice of funding opportunity (NOFO) linked from the official page: eligibility, cost sharing and evaluation criteria.
  2. Make sure your organisation has an active SAM.gov registration and Unique Entity ID (UEI); registration can take several weeks.
  3. For NIH: the organisation and the principal investigator also need eRA Commons accounts; applications are usually submitted through Grants.gov (for example with ASSIST).
  4. Prepare the required forms, narrative, budget and attachments exactly as the NOFO specifies.
  5. Submit before the deadline and keep the tracking number. Check for amendments before you submit.

From the call text

Who can apply
Not stated in the call text we hold — check the official page
Company stage
Not stated in the call text we hold — check the official page
Single applicant or consortium
Not stated in the call text we hold — check the official page
Where applicants must be based
Not stated in the call text we hold — check the official page
Where to apply
Not stated in the call text we hold — check the official page

Contact

National Institutes of Health · grantsinfo@nih.gov · 301-402-2541

Where these facts come from

FactValueHow we knowTaken from the source
Deadline7 January 2027official data field15 Nov 2026
Amount per applicantUp to $499,999official data field15 Nov 2026
Total budget$499,999official data field15 Nov 2026
Funding rateNo mandatory cost sharing stated; funding percentage not statedread from the official text15 Nov 2026
Who can applyPublic and State controlled institutions of higher education; State governments; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; Others (see text field entitled…official data field15 Nov 2026
Where to applyUnknown — not stated in the source we holdunknown—

Official sources

Official call page · Funder's programme page

Facts on this page come from the funder’s official data, taken on 13 Nov 2026. The funder's own documents, including later amendments, always take precedence.

More from National Institutes of Health

National Institutes of Health United States

Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High… (R34 Clinical Trial Required)

PAR-25-274

The goal of this notice of funding opportunity (NOFO) is to support feasibility trials of complementary and integrative health approaches with physical and/or psychologic…

National Institutes of Health United States

Investigator Initiated Clinical Trials of Complementary and Integrative… (R01 Clinical Trial Required)

PAR-25-268

This Notice of Funding Opportunity (NOFO) encourages applications for investigator-initiated fully remotely delivered and conducted clinical trials to assess the efficacy…

National Institutes of Health United States

Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)

PAR-25-158

This Notice of Funding Opportunity (NOFO) focuses on prevention and intervention strategies for fetal alcohol spectrum disorders (FASD) throughout the lifespan. The inten…